Comprehensive characterization of FBXW7 mutational and clinicopathological profiles in human colorectal cancers
BackgroundFBXW7 is recognized as a critical tumor suppressor gene and a component of the ubiquitin-proteasome system, mediating the degradation of multiple oncogenic proteins, including c-MYC, Cyclin E, c-Jun, Notch, p53. Around 16% of colorectal cancer (CRC) patients carried FBXW7 somatic mutations...
Main Authors: | Yiping Liu, Hanlin Chen, Hua Bao, Jinfeng Zhang, Runda Wu, Lingjun Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1154432/full |
Similar Items
-
FBXW7 and Its Downstream NOTCH Pathway Could be Potential Indicators of Organ-Free Metastasis in Colorectal Cancer
by: Dongzheng Li, et al.
Published: (2022-05-01) -
Alteration in Expression of miR-32 and FBXW7 Tumor Suppressor in Plasma Samples of Patients with T-cell Acute Lymphoblastic Leukemia
by: Mansouri S, et al.
Published: (2020-02-01) -
Examination of the expression levels of MACC1, Filamin A and FBXW7 genes in colorectal cancer patients
by: Funda Yeşilkaya, et al.
Published: (2020-02-01) -
Clinical significance of FBXW7 tumor suppressor gene mutations and expression in human colorectal cancer: a systemic review and meta-analysis
by: Wei Shang, et al.
Published: (2021-07-01) -
FBXW7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy
by: Yi Xiao, et al.
Published: (2018-06-01)